Discontinued — last reported Q4 '25

Investing

PP&E Sale Proceeds

Humana PP&E Sale Proceeds remained flat by 0.0% to $5.75M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 228.6%, from $1.75M to $5.75M. Over 4 years (FY 2021 to FY 2025), PP&E Sale Proceeds shows a downward trend with a -3.0% CAGR.

Analysis

StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ1 2013
Last reportedQ4 2025

How to read this metric

Significant proceeds may indicate a strategic shift, asset divestiture, or the replacement of obsolete equipment.

Detailed definition

This represents cash inflows from the disposal of property, plant, and equipment. It reflects the company's strategy for...

Peer comparison

Generally a minor line item unless the company is undergoing a major restructuring or facility consolidation.

Metric ID: proceeds_from_sale_of_ppe

Historical Data

5 years
 FY'21FY'22FY'23FY'24FY'25
Value$26.00M$17.00M$210.00M$7.00M$23.00M
YoY Change—-34.6%>999%-96.7%+228.6%
Range$7.00M – $210.00M
CAGR-3.0%
Avg YoY Growth+308.1%
Median YoY Growth+97.0%

Frequently Asked Questions

What is Humana's pp&e sale proceeds?
Humana (HUM) reported pp&e sale proceeds of $5.75M in Q4 2025.
How has Humana's pp&e sale proceeds changed year-over-year?
Humana's pp&e sale proceeds increased by 228.6% year-over-year, from $1.75M to $5.75M.
What is the long-term trend for Humana's pp&e sale proceeds?
Over 4 years (2021 to 2025), Humana's pp&e sale proceeds has grown at a -3.0% compound annual growth rate (CAGR), from $26.00M to $23.00M.
What does pp&e sale proceeds mean?
Cash received from selling off physical assets like buildings or machinery.